Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period
Title: Living Well Black Inc LWB Comment
Living Well Black Inc (LWB) - Comment
This is comment on Notice
Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period
View Comment
Attachments:
Living Well Black Inc LWB Comment
Title:
Living Well Black Inc LWB Comment
Related Comments
View AllPublic Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0011
Mar 18,2013 11:59 PM ET
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0006
Mar 18,2013 11:59 PM ET
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0027
Mar 18,2013 11:59 PM ET
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0019
Mar 18,2013 11:59 PM ET
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0020
Mar 18,2013 11:59 PM ET